-
effectivehealthcare.ahrq.gov/sites/default/files/cer-231-dementia-care-interventions-comments.pdf
July 31, 2020 - the science on dementia
and the movement of pharmacological interventions to
the MCI or preclinical phase … The systematic review
underwent a comprehensive topic refinement phase. … person-
centered care was foundational to determining the
included outcomes during the topic refinement phase … intervention, comparator, outcomes, timing, setting) were
derived from a comprehensive topic refinement phase … intervention, comparator,
outcomes, timing, setting) were derived from a
comprehensive topic refinement phase
-
effectivehealthcare.ahrq.gov/system/files/cer-231-dementia-care-interventions-comments.pdf
July 31, 2020 - the science on dementia
and the movement of pharmacological interventions to
the MCI or preclinical phase … The systematic review
underwent a comprehensive topic refinement phase. … person-
centered care was foundational to determining the
included outcomes during the topic refinement phase … intervention, comparator, outcomes, timing, setting) were
derived from a comprehensive topic refinement phase … intervention, comparator,
outcomes, timing, setting) were derived from a
comprehensive topic refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-231-dementia-care-interventions-disposition-comments.pdf
July 31, 2020 - the science on dementia
and the movement of pharmacological interventions to
the MCI or preclinical phase … The systematic review
underwent a comprehensive topic refinement phase. … person-
centered care was foundational to determining the
included outcomes during the topic refinement phase … intervention, comparator, outcomes, timing, setting) were
derived from a comprehensive topic refinement phase … intervention, comparator,
outcomes, timing, setting) were derived from a
comprehensive topic refinement phase
-
effectivehealthcare.ahrq.gov/products/headaches-pregnancy/protocol
November 12, 2019 - Do the (comparative) benefits and harms vary by phase (i.e., preconception, first trimester of pregnancy … Do the (comparative) benefits and harms vary by phase (i.e., preconception, first trimester of pregnancy … In particular, we will extract, as available, data on phase (i.e., preconception, first trimester of … Postpartum: The phase up to 12 months post-delivery. … Preconception: The phase during which women are attempting to become pregnant.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
March 23, 2019 - of primary headache and are
pregnant (or attempting to become pregnant, i.e., in the preconception phase … Do the (comparative) benefits and harms vary by phase (i.e., preconception, first
trimester of pregnancy … Do the (comparative) benefits and harms vary by phase (i.e., preconception, first
trimester of pregnancy … Population(s):
• Women who are pregnant (or attempting to become pregnant/in the preconception
phase … In particular, we will extract, as available, data on phase (i.e.,
preconception, first trimester of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-apbi-breast-cancer.pdf
April 01, 2017 - European Society for Radiotherapy and
Oncology (GEC-ESTRO) trial, 1184 patients were enrolled
in a phase … Data from other large randomized phase 3 trials
evaluating APBI, including the National Surgical Adjuvant … The Austrian Multi Institutional study has
reported its findings specifically for age.7 In this phase … Clinical trials
Two large phase 3 trials, the Intraoperative radiother-
apy with electrons (ELIOT) trial … Late toxicity and patient
self-assessment of breast appearance/satisfaction onRTOG0319: a phase
2 trial
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - III trials
for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … Results
The table below lists the 15 topics for which (1) preliminary phase III data for drugs, or phase … -week results from its phase II
trial. … At least six SGLT2 inhibitors are in phase II
and III trials. … Intarcia presents positive ITCA 650 phase 2
study results for type 2 diabetes at EASD.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - III trials
for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … Results
The table below lists the 15 topics for which (1) preliminary phase III data for drugs, or phase … -week results from its phase II
trial. … At least six SGLT2 inhibitors are in phase II
and III trials. … Intarcia presents positive ITCA 650 phase 2
study results for type 2 diabetes at EASD.
-
effectivehealthcare.ahrq.gov/products/colorectal-cancer-hepatic-therapy/abstract
January 19, 2010 - National Cancer Institute’s Cancer Care Outcomes Research and Surveillance Consortium (CANCORS), and a phase
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
December 14, 2017 - Allergan is conducting a Phase III development
program specifically in the United States with two Phase … The first positive Phase III trial results have been
already released and the second Phase III trial … See below for correction of identified errors with regard to European
Phase III trials. … This now includes the two Donnez Phase III trials discussed above. … Two of the four Ulipristal trials
consisted of small Phase II studies.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/iom-standards_white-paper.pdf
April 01, 2013 - A two-phase approach is adopted, where in phase one, 13 EPC directors, in
consultation with their respective … identified areas where general agreement exist and where
further deliberation was necessary, and in phase … Summary of phase 2 discussion by workgroup (N=34) ................................................... … During an initial phase (phase 1), all EPC
directors, in consultation with their staff, were requested … The second phase (phase 2) of the process focused on the standards or elements in either
category 2
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-radiation-therapy-bone-metastases.pdf
August 01, 2022 - Short-course regimen of palliative radiotherapy in
complicated bone metastases: a phase i-ii study ( … A phase I dose-escalation trial of stereotactic ablative
body radiotherapy for non-spine bone and lymph … A
Prospective Randomized Phase II Study of 1 vs 2 Fractions of Palliative Radiation Therapy for
Patients … A phase III randomized-controlled, single-blind trial to
improve quality of life with stereotactic body … Radiotherapy for Pain Relief in
Patients With Predominantly Nonspine Bone Metastases: a Randomized Phase
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-apbi-breast-cancer.pdf
August 01, 2022 - early breast cancer (UK IMPORT LOW trial): 5-year results from a
multicentre, randomised, controlled, phase … QOL After APBI (Multicatheter Brachytherapy) Versus WBI: 5-
Year Results, Phase 3 GEC-ESTRO Trial. … in early breast cancer
after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase … Randomized phase II study of hypofractionated WBI versus
APBI using VMAT: early toxicity results. … A phase II trial to determine the cosmetic outcomes and
toxicity of 27 Gy in five-fraction accelerated
-
effectivehealthcare.ahrq.gov/products/cardiac-defibrillators/abstract
December 15, 2009 - Expected date of project completion: Phase 1 will be completed in September, 2011
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/quality-rating_research.pdf
November 01, 2011 - Research Report
A Process for Robust and Transparent Rating
of Study Quality: Phase … Methods Research Report
A Process for Robust and Transparent Rating
of Study Quality: Phase … A Process for Robust and Transparent
Rating of Study Quality: Phase 1. Methods Research Report. … Purpose: To complete the first phase of a project to develop such a methodology, we aimed to
examine … In an effort to develop such a methodology, we completed the first phase of a project that
aimed to
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
October 01, 2014 - without HCC to identify
lesions in the liver that are clinically suspicious for HCC.4
The evaluation phase … imaging,
timing of delayed phase imaging (≥120 seconds after
administration of contrast or <120 s) … Studies with delayed phase imaging reported somewhat higher
sensitivity (0.89; 95% CI, 0.81 to 0.94; … 7 studies) than studies without
delayed phase imaging (0.74; 95% CI, 0.66 to 0.87; 7 studies). … imaging, timing of delayed phase imaging, and section thickness.
-
effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
January 01, 2012 - A phase II/III trial began in 2010 for
acquired hemophilia and is ongoing. … A phase III trial started in late 2011 to treat hemophilia
A (congenital hemophilia) is ongoing. … Placebo-
controlled phase 3 study of oral BG-12 for
relapsing multiple sclerosis. … Placebo-
controlled phase 3 study of oral BG-12 or
glatiramer in multiple sclerosis. … ThromboGenics'
microplasmin phase III program progressing
according to schedule. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0274_03-10-2008.pdf
January 01, 2008 - populations, interventions,
comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/products/cultural-competence/research-protocol
July 08, 2014 - The literature set identified at this phase will be examined from a content analysis perspective for … 36
double blind method/
37
single blind method/
38
clinical trial/
39
clinical trial, phase … i.pt.
40
clinical trial, phase ii.pt.
41
clinical trial, phase iii.pt.
42
clinical trial … i.pt.
40
clinical trial, phase ii.pt.
41
clinical trial, phase iii.pt.
42
clinical trial … i.pt.
40
clinical trial, phase ii.pt.
41
clinical trial, phase iii.pt.
42
clinical trial
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - phase II or equivalent data for devices and procedures, or some human data for off-label uses or … In March 2013, Intarcia began phase III trials of ITCA 650/pump system. … This drug will compete with other drugs in
phase III trials, such as Iluvien and aflibercept (Eylea … In March 2013, ITCA 650’s developer announced enrolling the first patients in its phase III
FREEDOM … Intarcia presents positive ITCA 650 phase 2 study
results for type 2 diabetes at EASD.